Postoperative Pain in the Surgical Treatment of Hemorrhoids: Conventional Hemorrhoidectomy With a Monopolar Electric Scaler VS Bipolar Energy With Caiman® (Aesculap®)

Launched by CORPORACION PARC TAULI · Aug 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different methods for treating hemorrhoids to see which one causes less pain after surgery. The two methods being compared are a traditional surgery called hemorrhoidectomy using a monopolar electric scalpel and another method using a device called Caiman® that uses bipolar energy. The goal is to find out if the pain after the Caiman® surgery, combined with regular oral pain medication, is at least as manageable as the pain after the monopolar surgery, which uses stronger pain relief given through an IV (intravenous).

To participate in this trial, patients need to be adults with certain types of hemorrhoids that are causing problems. Specifically, they should have grade III or IV hemorrhoids and be able to undergo outpatient surgery. Patients who are interested must agree to join the study and be in good health (classified as ASA I-III, which means they are generally well). Those with certain health issues, like severe allergies to pain medications or other serious conditions, cannot join. If you take part in this trial, you can expect to receive one of the two surgical treatments and be monitored for any pain after your procedure. Your participation will help researchers understand the best ways to manage pain after hemorrhoid surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with 2 or 3 bundles of grade III-IV hemorrhoids (Goligher classification) clinically symptomatic and subject to outpatient hemorrhoidectomy
• • Voluntary participation.
• • ASA I-II-III.
• Exclusion Criteria:
• • Failure to meet the inclusion criteria.
• • ASA IV.
• • Allergic to Paracetamol, derivatives of morphine.
• • Allergic to NSAIDs.
• • Synchronous colorectal neoplasia.
• • Coagulation disorders.
• • Thrombosed hemorrhoid.
• • Inflammatory bowel disease.
• • Liver cirrhosis and/or portal hypertension.
• • Pregnant women.
• • Difficulty following up by phone and/or in person.